Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „Rivaroxaban Accord“
Suchtreffer
Begriffe & Kennungen
Rivaroxaban Accord · 4.4 Special warnings and precautions for use · 1
Eintrag öffnenRivaroxaban Accord · 4.4 Special warnings and precautions for use · 2
Eintrag öffnenRivaroxaban Accord · 4.4 Special warnings and precautions for use · 3
Eintrag öffnenRivaroxaban Accord · 4.4 Special warnings and precautions for use · 4
Eintrag öffnenRivaroxaban Accord · 4.4 Special warnings and precautions for use · 5
Eintrag öffnenRivaroxaban Accord · 4.5 Interaction with other medicinal products and other forms of interaction · 1
Eintrag öffnenRivaroxaban Accord · 4.5 Interaction with other medicinal products and other forms of interaction · 2
Eintrag öffnenRivaroxaban Accord · 4.5 Interaction with other medicinal products and other forms of interaction · 3
Eintrag öffnenRivaroxaban Accord · 4.5 Interaction with other medicinal products and other forms of interaction · 4
Eintrag öffnenRivaroxaban Accord · 4.5 Interaction with other medicinal products and other forms of interaction · 5
Eintrag öffnenRivaroxaban Accord · 4.5 · 126 No clinically significant pharmacokinetic or pharmacodynamic interactions were observed when rivaroxaban w
Eintrag öffnenRivaroxaban Accord · 4.5 · 94 Erythromycin (500 mg three times a day), which inhibits CYP3A4 and P-gp moderately, led to a 1.3-fold incre
Eintrag öffnenRivaroxaban Accord · 4.5 · Active substances strongly inhibiting only one of the rivaroxaban elimination pathways, either CYP3A4 or P-gp,
Eintrag öffnenRivaroxaban Accord · 4.5 · Active substances strongly inhibiting only one of the rivaroxaban elimination pathways, either CYP3A4 or P-gp,
Eintrag öffnenRivaroxaban Accord · 4.5 · Active substances strongly inhibiting only one of the rivaroxaban elimination pathways, either CYP3A4 or P-gp,
Eintrag öffnenRivaroxaban Accord · 4.5 · Active substances strongly inhibiting only one of the rivaroxaban elimination pathways, either CYP3A4 or P-gp,
Eintrag öffnenRivaroxaban Accord · 4.5 · Active substances strongly inhibiting only one of the rivaroxaban elimination pathways, either CYP3A4 or P-gp,
Eintrag öffnenRivaroxaban Accord · 4.5 · After combined administration of enoxaparin (40 mg single dose) with rivaroxaban (10 mg single dose) an additi
Eintrag öffnenRivaroxaban Accord · 4.5 · After combined administration of enoxaparin (40 mg single dose) with rivaroxaban (10 mg single dose) an additi
Eintrag öffnenRivaroxaban Accord · 4.5 · After combined administration of enoxaparin (40 mg single dose) with rivaroxaban (10 mg single dose) an additi
Eintrag öffnen